 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--- QNCX--Quince Therapeutics, Inc. Nasdaq: QNCX, a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced that the company will present at a number of scientific meetings taking place in September 2022, including the 14th International Conference on Osteogenesis Imperfecta OI 2022, The American Society for Bone and Mineral Research Annual Meeting ASBMR 2022, and the Military Health Syst 